GlobeNewsWire
01 Sept 2026, 22:43 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
4 claims · each scored for market impact
The Portnoy Law Firm has announced a class action lawsuit against Fractyl Health (GUTS) alleging false and misleading statements regarding the efficacy of its Revita DMR System. — Class action lawsuits create significant legal overhang and investor uncertainty, often leading to sustained downward pressure on stock price.
-0.60Six-month data from the REMAIN-1 Midpoint Cohort showed a 4.5% weight regain for Revita-treated patients versus 7.5% in the sham arm, which fell short of investor expectations. — Poor clinical trial efficacy results for a core product directly impair the company's projected revenue and commercial viability.
-0.50Morgan Stanley downgraded Fractyl Health from 'Overweight' to 'Equal-weight' and slashed its price target from $8.00 to $2.00. — A massive reduction in price target and a rating downgrade by a major institutional analyst typically triggers institutional selling.
-0.40Continue reading
6 related stories
Search tags
Fractyl Health management attributed disappointing trial results partly to operational issues and poor diet counseling at one of the six clinical study sites. — While providing a potential explanation for poor data, attributing failure to operational errors can be seen as a sign of poor management oversight.
-0.20Which stocks this story touches
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
3h ago
